NYSE:RDY - New York Stock Exchange, Inc. - US2561352038 - ADR - Currency: USD
Overall RDY gets a fundamental rating of 6 out of 10. We evaluated RDY against 195 industry peers in the Pharmaceuticals industry. RDY gets an excellent profitability rating and is at the same time showing great financial health properties. RDY has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.43% | ||
ROE | 16.84% | ||
ROIC | 14.5% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 21.27% | ||
PM (TTM) | 17.3% | ||
GM | 69.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | 3.89 | ||
Altman-Z | 6.44 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.92 | ||
Quick Ratio | 1.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 19.09 | ||
Fwd PE | 17.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 89.63 | ||
EV/EBITDA | 11.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.62% |
15.08
0 (0%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.62% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 19.09 | ||
Fwd PE | 17.83 | ||
P/S | 3.3 | ||
P/FCF | 89.63 | ||
P/OCF | 23.22 | ||
P/B | 3.21 | ||
P/tB | 4.78 | ||
EV/EBITDA | 11.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.43% | ||
ROE | 16.84% | ||
ROCE | 19.08% | ||
ROIC | 14.5% | ||
ROICexc | 17.42% | ||
ROICexgc | 27.35% | ||
OM | 21.27% | ||
PM (TTM) | 17.3% | ||
GM | 69.43% | ||
FCFM | 3.69% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | 3.89 | ||
Debt/EBITDA | 0.09 | ||
Cap/Depr | 201.9% | ||
Cap/Sales | 10.54% | ||
Interest Coverage | 19.93 | ||
Cash Conversion | 53.7% | ||
Profit Quality | 21.3% | ||
Current Ratio | 1.92 | ||
Quick Ratio | 1.37 | ||
Altman-Z | 6.44 |